SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-005524
Filing Date
2021-11-12
Accepted
2021-11-12 16:01:48
Documents
36
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cns_i10q-093021.htm   iXBRL 10-Q 467002
2 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY cns_ex1001.htm EX-10.1 10095
3 CERTIFICATION BY CHIEF EXECUTIVE OFFICER cns_ex3101.htm EX-31.1 7059
4 CERTIFICATION BY CHIEF FINANCIAL OFFICER cns_ex3102.htm EX-31.2 7025
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER cns_ex3201.htm EX-32.1 3455
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER cns_ex3202.htm EX-32.2 3455
  Complete submission text file 0001683168-21-005524.txt   2331409

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cnsp-20210930.xsd EX-101.SCH 19134
8 XBRL CALCULATION FILE cnsp-20210930_cal.xml EX-101.CAL 23998
9 XBRL DEFINITION FILE cnsp-20210930_def.xml EX-101.DEF 88943
10 XBRL LABEL FILE cnsp-20210930_lab.xml EX-101.LAB 200105
11 XBRL PRESENTATION FILE cnsp-20210930_pre.xml EX-101.PRE 149889
12 EXTRACTED XBRL INSTANCE DOCUMENT cns_i10q-093021_htm.xml XML 217271
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39126 | Film No.: 211403215
SIC: 2834 Pharmaceutical Preparations